Congresses

Simultaneous Multi-Cancer Detection and Tissue of Origin Prediction Via Targeted Bisulfite Sequencing of Plasma Cell-Free DNA

October 16, 2020

Analytical Validation of a Multi-Cancer Early Detection Test With Tissue Localization Using a Cell-Free DNA-Based Targeted Methylation Assay

June 24, 2020

Classifier Performance of a cfDNA-Based Multi-Cancer Detection Test on Uncommon Cancer Types

HPV-Driven Cancers Show Distinct Methylation Signatures in Cell-Free DNA (cfDNA)

cfDNA Methylation Profiling Distinguishes Lineage-Specific Hematologic Malignancies

Tumor Methylation Patterns Accurately Measure Tumor Fraction in Cell-free DNA

May 29, 2020

Tumor Area and Microscopic Extent of Invasion to Estimate Circulating Tumor DNA Fraction in Plasma and Detectability of Colorectal Cancer

May 5, 2020

Simultaneous Multi-cancer Detection and Tissue of Origin (TOO) Localization Using Targeted Bisulfite Sequencing of Plasma Cell-free DNA (cfDNA)

May 3, 2020

AACR Virtual Annual Meeting I

April 28, 2020

Prediction of Cancer and Tissue of Origin in Individuals with Suspicion of Cancer Using a Cell-Free DNA Multi-Cancer Early Detection Test

The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice

Tumor Area and Microscopic Extent of Invasion to Estimate Circulating Tumor DNA Fraction in Plasma and Detectability of Colorectal Cancer

January 24, 2020

Performance of a Blood-based Test for the Detection of Multiple Cancer Types

January 23, 2020

Oral Presentation: Performance of A Blood-based Test for the Detection of Multiple Cancer Types

Blood-based cancer detection in plasma cell-free DNA (cfDNA): evaluating clinical and pathologic tumor characteristics in participants with breast cancer

December 13, 2019

Oral Presentation: Novel non-invasive cell-free nucleic acid-based diagnostic test for liver fibrosis in patients with type II diabetes

November 10, 2019

Optimized Early Cancer Detection from Whole-Genome Sequencing of Cell-Free DNA

October 16, 2019

Oral Presentation: Simultaneous multi-cancer detection and tissue of origin (TOO) localization using targeted bisulfite sequencing of plasma cellfree DNA (cfDNA)

October 11, 2019

Simultaneous Multi-cancer Detection and Tissue of Origin (TOO) Localization Using Targeted Bisulfite Sequencing of Plasma Cell-free DNA (cfDNA)

Oral Presentation: Multi-cancer detection of early-stage cancers with simultaneous tissue localization using a plasma cfDNA-based targeted methylation assay

September 27, 2019

Trial in Progress: Cancer Screening Study With or Without Low Dose Lung CT to Validate a Multi-cancer Early Detection Blood Test: SUMMIT

September 8, 2019

Prognostic Significance of Blood-based Cancer Detection in Plasma Cell-free DNA (cfDNA): Evaluating Risk of Overdiagnosis

June 3, 2019

The Circulating Cell-free Genome Atlas (CCGA) Study: Follow-up (F/U) on Non-cancer Participants with Cancer-like Cell-free DNA Signals

June 1, 2019

The Circulating Cell-free Genome Atlas (CCGA) Study: Size Selection of Cell-free DNA (cfDNA) Fragments

Genome-wide Cell-free DNA (cfDNA) Methylation Signatures and Effect on Tissue of Origin (TOO) Performance

MODELING REDUCTIONS IN ABSOLUTE CANCER MORTALITY FROM DIAGNOSING CANCERS BEFORE METASTASIS, 2006-2015

May 22, 2019

Tumor Shedding into Cell-free DNA (cfDNA) is Associated with High-mortality Cancers

May 10, 2019

Detection of Tissue-specific RNA in the Plasma of Cancer Patients: A Circulating Cell-free Genome Atlas (CCGA) Substudy

May 9, 2019

Cell-free DNA (cfDNA) Fragment Length Patterns of Tumor- and Blood-derived Variants in Participants With and Without Cancer

April 2, 2019

Plasma-Based Molecular Testing for Early Detection of Lung Cancer

November 8, 2018

Plasma Cell-free DNA (cfDNA) Assays for Early Multi-cancer Detection: the Circulating Cell-free Genome Atlas (CCGA) Study

October 19, 2018

Prevalence of clonal hematopoiesis of indeterminate potential (CHIP) measured by an ultra-sensitive sequencing assay: exploratory analysis of the Circulating Cell-free Genome Atlas (CCGA) study

June 5, 2018

Genome-Wide Sequencing for Early Stage Lung Cancer Detection from Plasma Cell-Free DNA (cfDNA): The Circulating Cell-free Genome Atlas (CCGA) Study

June 4, 2018

Development of a comprehensive cell-free DNA (cfDNA) assay for early detection of multiple tumor types: The Circulating Cell-free Genome Atlas (CCGA) study

Breast Cancer Cell- free DNA (cfDNA) Profiles Reflect Underlying Tumor Biology: The Circulating Cell-free Genome Atlas (CCGA) Study

June 2, 2018

Development of Plasma Cell-Free DNA Assays for Early Cancer Detection: First Insights from the Circulating Cell- Free Genome Atlas (CCGA) Study

April 17, 2018

Development of Cell-Free Nucleic Acid-Based Tests for Detection of invasive breast cancer: The STRIVE Study

December 8, 2017

Conta: Methods for detecting trace amounts of contamination

July 24, 2017

Performance of a high-intensity 508-gene circulating-tumor DNA (ctDNA) assay in patients with metastatic breast, lung, and prostate cancer

June 3, 2017

Many cell-free DNA (cfDNA) mutations are derived from clonal hematopoiesis: Implications for interpretation of liquid biopsy tests